Trial of Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism (TARGET-PA)

Clinical trial NCT07297745 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07297745
Sponsor: Changi General Hospital
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Hyperaldosteronism; Primary Primary Aldosteronism Due to Aldosterone Producing Adenoma

Start date: 2026-01-15
Primary completion: 2029-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.